Stay updated on Nivolumab, Tadalafil, Vancomycin in Liver Cancer Clinical Trial

Sign up to get notified when there's something new on the Nivolumab, Tadalafil, Vancomycin in Liver Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab, Tadalafil, Vancomycin in Liver Cancer Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov record for a Phase 2 study of nivolumab, tadalafil, and oral vancomycin is displayed, including eligibility, treatment, outcomes, and results information. The record states that the study was terminated due to poor accrual.
    Difference
    70%
    Check dated 2026-11-07T11:39:57.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The footer now identifies the site as revision v3.8.0 instead of v3.7.2. The study record remains inaccessible behind a 403 Forbidden page.
    Difference
    0.2%
    Check dated 2026-10-31T12:13:27.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    A banner announces NIH website transition updates and says that federal agencies are using “Super Intelligence” in place of “Artificial Intelligence” during the transition.
    Difference
    1%
    Check dated 2026-10-24T11:45:45.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The footer revision label was updated from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-17T12:26:46.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The footer’s site revision identifier changed from v3.7.0 to v3.7.1; the page continues to show a 403 error.
    Difference
    0.2%
    Check dated 2026-10-10T12:38:52.000Z thumbnail image
  7. Check
    57 days ago
    Change Detected
    Summary
    The study page now displays a 403 Forbidden error instead of the study details, indicating access to the record is blocked. A minimal Home option is shown in the footer, reflecting the restricted access state.
    Difference
    22%
    Check dated 2026-09-19T20:51:18.000Z thumbnail image

Stay in the know with updates to Nivolumab, Tadalafil, Vancomycin in Liver Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab, Tadalafil, Vancomycin in Liver Cancer Clinical Trial page.